KK
KLP Kapitalforvaltning Portfolio holdings
AUM
$23.2B
This Quarter Return
+4.67%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$21.1B
AUM Growth
–
Cap. Flow
+$21.1B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
31.62%
Holding
2,288
New
2,288
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Apple
AAPL
|
+$1.45B |
| 2 |
NVIDIA
NVDA
|
+$1.23B |
| 3 |
Microsoft
MSFT
|
+$1.12B |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Meta Platforms (Facebook)
META
|
+$447M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 32.86% |
| 2 | Financials | 13.45% |
| 3 | Consumer Discretionary | 11.11% |
| 4 | Healthcare | 10.73% |
| 5 | Communication Services | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Enliven Therapeutics
ELVN
$1.18B
| $96.8K | ﹤0.01% |
+4,300
| New | +$96.8K |
|
2102
SI-BONE Inc
SIBN
$704M
| $96.7K | ﹤0.01% |
+6,900
| New | +$96.7K |
|
2103
Scholastic
SCHL
$687M
| $96K | ﹤0.01% |
+4,500
| New | +$96K |
|
|
KREF
2104
KKR Real Estate Finance Trust
KREF
$638M
| $95.9K | ﹤0.01% |
+9,300
| New | +$95.9K |
|
2105
Farmers National Banc Corp
FMNB
$570M
| $95.3K | ﹤0.01% |
+6,700
| New | +$95.3K |
|
2106
Dr. Reddy's Laboratories
RDY
$12.3B
| $94.7K | ﹤0.01% |
+6,000
| New | +$94.7K |
|
2107
Root
ROOT
$1.54B
| $94.4K | ﹤0.01% |
+1,300
| New | +$94.4K |
|
2108
Kearny Financial
KRNY
$421M
| $94.2K | ﹤0.01% |
+13,300
| New | +$94.2K |
|
|
FNA
2109
DELISTED
Paragon 28, Inc.
FNA
| $94K | ﹤0.01% |
+9,100
| New | +$94K |
|
2110
ZipRecruiter
ZIP
$430M
| $93.4K | ﹤0.01% |
+12,900
| New | +$93.4K |
|
2111
Acco Brands
ACCO
$372M
| $92.4K | ﹤0.01% |
+17,600
| New | +$92.4K |
|
2112
Thryv Holdings
THRY
$571M
| $91.8K | ﹤0.01% |
+6,200
| New | +$91.8K |
|
2113
Claros Mortgage Trust
CMTG
$533M
| $91.8K | ﹤0.01% |
+20,300
| New | +$91.8K |
|
2114
B&G Foods
BGS
$369M
| $91.7K | ﹤0.01% |
+13,000
| New | +$91.7K |
|
2115
Cantaloupe
CTLP
$792M
| $91.3K | ﹤0.01% |
+9,600
| New | +$91.3K |
|
2116
Ibotta
IBTA
$774M
| $91.1K | ﹤0.01% |
+1,400
| New | +$91.1K |
|
2117
Capricor Therapeutics
CAPR
$294M
| $91.1K | ﹤0.01% |
+6,600
| New | +$91.1K |
|
2118
Smith & Wesson
SWBI
$416M
| $90.9K | ﹤0.01% |
+8,900
| New | +$90.9K |
|
2119
RPC Inc
RES
$1.03B
| $90.9K | ﹤0.01% |
+15,300
| New | +$90.9K |
|
|
GMRE
2120
Global Medical REIT
GMRE
$511M
| $90.8K | ﹤0.01% |
+11,500
| New | +$90.8K |
|
2121
P10
PX
$1.36B
| $90.8K | ﹤0.01% |
+7,200
| New | +$90.8K |
|
2122
Amalgamated Financial
AMAL
$870M
| $90.4K | ﹤0.01% |
+2,700
| New | +$90.4K |
|
2123
Portillo's
PTLO
$442M
| $90.2K | ﹤0.01% |
+9,600
| New | +$90.2K |
|
2124
Keros Therapeutics
KROS
$640M
| $90.2K | ﹤0.01% |
+5,700
| New | +$90.2K |
|
2125
EverQuote
EVER
$903M
| $90K | ﹤0.01% |
+4,500
| New | +$90K |
|